Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-free or calcineurin inhibitor-minimized immunosuppression after basiliximab induction in kidney transplantation
NL-OMON34397Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of basiliximab, tacrolimus, mycophenolate mofetil and corticosteroids in kidney transplant and kidney allograft rejection (3 arms), sponsored by University Medical Center Groningen. Primary endpoints: Renal function parameters, Proteinuria and 4 more. Started Jun 2011; status: active, not recruiting.
02
Drugs
basiliximabtacrolimusmycophenolate mofetilcorticosteroids
03
Conditions
kidney transplantkidney allograft rejection
Beyond the preview
Go deeper on NL-OMON34397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34397.